导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 14.83% | 1106/4982 |
| 近一周 | 4.16% | 130/5419 |
| 近一月 | 2.17% | 278/5423 |
| 近一季 | -11.96% | 3461/5376 |
| 近半年 | 7.02% | 1351/5131 |
| 近一年 | 5.29% | 2180/4741 |
| 近两年 | 56.09% | 2074/4208 |
| 近三年 | 39.47% | 1444/3661 |
| 成立以来 | 49.83% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.38% 1959/5130 |
43.92% 1206/5464 |
- - |
- - |
| 2025 | 2.99% 4268/5130 |
0.73% 3408/4624 |
-0.35% 3362/4802 |
12.05% 3837/4970 |
-8.43% 4224/5130 |
| 2024 | 11.81% 864/4618 |
-4.40% 2475/4340 |
-6.87% 3491/4442 |
15.58% 774/4550 |
8.65% 338/4618 |
| 2023 | 3.21% 169/4216 |
0.16% 2309/3759 |
-3.94% 1823/3909 |
2.81% 78/4055 |
4.34% 148/4209 |
| 2022 | -24.50% 1751/3578 |
-14.56% 764/2804 |
-1.22% 2681/3205 |
-5.05% 254/3430 |
-5.79% 2743/3570 |
| 2021 | 10.00% 613/2717 |
-9.95% 1449/1745 |
26.72% 138/2232 |
-10.08% 1731/2560 |
7.20% 414/2708 |
| 2020 | 76.71% 200/1596 |
-10.87% 965/1036 |
36.62% 87/1256 |
20.64% 91/1472 |
20.30% 279/1690 |
| 2019 | 45.60% 308/926 |
20.50% 1342/3053 |
5.22% 149/3201 |
9.08% 279/939 |
5.28% 800/1014 |
| 2018 | -43.70% 529/668 |
- - |
-16.20% 2819/2983 |
-16.09% 2855/2970 |
-16.82% 2803/2975 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 0.9797 | 54.69% |
| 招商创新增长混合A | 1.0526 | 54.25% |
| 招商创新增长混合C | 1.0013 | 53.96% |
| 华泰柏瑞医疗健康A | 2.5834 | 49.29% |
| 招商品质成长混合A | 1.0196 | 49.15% |
| 大摩优悦安和混合A | 0.8851 | 47.23% |
| 大摩优悦安和混合C | 0.8688 | 47.08% |
| 华泰柏瑞医疗健康C | 2.5230 | 44.21% |
| 大摩健康产业混合A | 1.9140 | 32.70% |
| 中信建投医药健康A | 0.7640 | 31.75% |
| 南华瑞盈混合发起C VS. 长安宏观策略混合A(740001) |